Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge (Q24652737)

10

object named as

Erwin W Gelfand

0 references

author name string

Atsushi Hirano

1

0 references

Arihiko Kanehiro

2

0 references

Katsuichiro Ono

3

0 references

Wataru Ito

4

0 references

Akio Yoshida

5

0 references

Chiharu Okada

6

0 references

Hiromi Nakashima

7

0 references

Yasushi Tanimoto

8

0 references

Mikio Kataoka

American Journal of Respiratory Cell and Molecular Biology

9

0 references

language of work or name

English

0 references

publication date

September 2006

0 references

published in

0 references

volume

35

0 references

page(s)

366-77

0 references

issue

3

0 references

cites work

Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Future research directions in asthma: an NHLBI Working Group report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Inhibition of airway remodeling in IL-5-deficient mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Pirfenidone effectively reverses experimental liver fibrosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Airway remodeling in asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Pirfenidone improves renal function and fibrosis in the post-obstructed kidney

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity

19 June 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Pirfenidone attenuates ischaemia-reperfusion injury in the rat small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Is idiopathic pulmonary fibrosis now treatable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

The questionable efficacy of pirfenidone in IPF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Poor choice of primary outcome in a clinical trial of pirfenidone in patients with IPF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Fluticasone inhibits but does not reverse allergen-induced structural airway changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Platelet-derived growth factor is involved in the augmentation of airway responsiveness through remodeling of airways in diesel exhaust particulate-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643289

Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis

28 November 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Increased release of transforming growth factor (TGF)-beta1, TGF-beta2, and chemoattractant mediators in pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Negative regulation of airway responsiveness that is dependent on gammadelta T cells and independent of alphabeta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Modifications of a specific assay for hydroxyproline in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2005-0452OC

Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma

21 January 2018

1 reference

12 December 2020

Interleukin-13 and interleukin-4 are coexpressed in atopic asthma

1 reference

12 December 2020

Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics

1 reference

12 December 2020

1 reference

12 December 2020

Airway fibrosis in rats induced by vanadium pentoxide

1 reference

12 December 2020

Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension

1 reference

12 December 2020